LPL Financial LLC raised its holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 6.7% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,710 shares of the biopharmaceutical company’s stock after acquiring an additional 925 shares during the quarter. LPL Financial […]
StockNews com Initiates Coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Connor Clark & Lunn Investment Management Ltd. boosted its stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 940.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,901 shares of the biopharmaceutical company’s stock after purchasing an additional 11,661 […]
Stock analysts at StockNews.com assumed coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also commented on ALNY. Sanford C. Bernstein cut their price objective on shares of Alnylam […]
Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $178.71 and last traded at $178.78, with a volume of 121505 shares traded. The stock had previously closed at $181.35. Analyst Ratings Changes ALNY has been the subject […]